Our work illustrates that nutlin-3a-loaded ethosomes successfully trigger p53-dependent apoptosis, impede cell migration, and diminish Notch-1 signaling in p53wild-type melanoma cells, indicating a feasible strategy for targeted melanoma treatment. Here, TP53 is linked to melanoma.